Literature DB >> 1434968

Results and impacts of the Resource-Based Relative Value Scale.

W C Hsiao1, P Braun, E R Becker, D L Dunn, N Kelly, N Causino, M D McCabe, E Rodriguez.   

Abstract

On January 1, 1992, the Health Care Financing Administration implemented the 1989 legislation reforming the Medicare payment system for physicians' services. The cornerstone of the new payment reform is the Medicare Fee Schedule (MFS), which is based on the Resource-Based Relative Value Scale (RBRVS). In this article, the major findings of the RBRVS study and its impacts on physician payment are summarized. The authors report the impacts of a RBRVS-based fee schedule on Medicare fees and physicians' income if it were fully implemented, assuming budget neutrality and absence of volume changes in services. Under this scenario, fees for evaluation and management services increase by 15% to 45%, while fees for invasive services and diagnostic tests decrease by 20% to 30%. These changes increase the Medicare income of family practitioners by more than 30% while decreasing the income of most surgical specialties by 10% to 20%.

Mesh:

Year:  1992        PMID: 1434968     DOI: 10.1097/00005650-199211001-00006

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  4 in total

1.  Member risk adjustment for ambulatory episodes of care.

Authors:  D J Brailer; E A Kroch
Journal:  Health Care Manag Sci       Date:  1999-07

2.  Development of a local model for measuring the work of surgeons.

Authors:  Sara Forootan; Sakineh Hajebrahimi; Ali Janati; Behzad Najafi; Mohammad Asghari-Jafarabadi
Journal:  Turk J Surg       Date:  2021-12-31

Review 3.  Effects of selected cost-containment efforts: 1971-1993.

Authors:  M Gold; K Chu; S Felt; M Harrington; T Lake
Journal:  Health Care Financ Rev       Date:  1993

4.  Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease.

Authors:  Shan Tang; Jiachu Ma; Huaxing Meng; Junhong Guo; Shuyan Cao; Binquan Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.